244
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Epigenome-Wide Analysis of DNA Methylation Reveals a Rectal Cancer-Specific Epigenomic Signature

, , , , , , , , & show all
Pages 1193-1207 | Received 20 Apr 2016, Accepted 28 Jun 2016, Published online: 16 Aug 2016

References

  • Haggar FA , BousheyRP . Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors . Clin. Colon Rectal Surg.22 ( 4 ), 191 – 197 ( 2009 ).
  • Comprehensive molecular characterization of human colon and rectal cancer . Nature487 ( 7407 ), 330 – 337 ( 2012 ).
  • Wolpin BM , MeyerhardtJA , MamonHJ , MayerRJ . Adjuvant treatment of colorectal cancer . CA Cancer J. Clin.57 ( 3 ), 168 – 185 ( 2007 ).
  • Minsky BD . Counterpoint: long-course chemoradiation is preferable in the neoadjuvant treatment of rectal cancer . Semin. Radiat. Oncol.21 ( 3 ), 228 – 233 ( 2011 ).
  • Zlobec I , VuongT , HayashiSet al. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy . Br. J. Cancer96 ( 5 ), 793 – 800 ( 2007 ).
  • Wei EK , GiovannucciE , WuKet al. Comparison of risk factors for colon and rectal cancer . Int. J. Cancer108 ( 3 ), 433 – 442 ( 2004 ).
  • Colditz GA , CannuscioCC , FrazierAL . Physical activity and reduced risk of colon cancer: implications for prevention . Cancer Causes Control8 ( 4 ), 649 – 667 ( 1997 ).
  • Servomaa K , KiuruA , KosmaVM , HirvikoskiP , RytomaaT . p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women . Mol. Pathol.53 ( 1 ), 24 – 30 ( 2000 ).
  • Sharma S , KellyTK , JonesPA . Epigenetics in cancer . Carcinogenesis31 ( 1 ), 27 – 36 ( 2010 ).
  • Wilson AS , PowerBE , MolloyPL . DNA hypomethylation and human diseases . Biochim. Biophys. Acta1775 ( 1 ), 138 – 162 ( 2007 ).
  • Esteller M . CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future . Oncogene21 ( 35 ), 5427 – 5440 ( 2002 ).
  • Pfeifer GP , RauchTA . DNA methylation patterns in lung carcinomas . Semin. Cancer Biol.19 ( 3 ), 181 – 187 ( 2009 ).
  • Farkas SA , VymetalkovaV , VodickovaL , VodickaP , NilssonTK . DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/beta-catenin signaling pathway genes . Epigenomics6 ( 2 ), 179 – 191 ( 2014 ).
  • Lindqvist BM , WingrenS , MotlaghPB , NilssonTK . Whole genome DNA methylation signature of HER2-positive breast cancer . Epigenetics9 ( 8 ), 1149 – 1162 ( 2014 ).
  • Naumov VA , GenerozovEV , ZaharjevskayaNBet al. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips . Epigenetics8 ( 9 ), 921 – 934 ( 2013 ).
  • The Cancer Genome Atlas Research Network ( 2012 ). http://cancergenome.nih.gov/ .
  • Yousefi P , HuenK , Aguilar SchallRet al. Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies . Epigenetics8 ( 11 ), 1141 – 1152 ( 2013 ).
  • Sandoval J , HeynH , MoranSet al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome . Epigenetics6 ( 6 ), 692 – 702 ( 2011 ).
  • Nordlund J , BacklinCl , WahlbergPet al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia . Genome Biol.14 ( 9 ), r105 ( 2013 ).
  • Bibikova M , BarnesB , TsanCet al. High density DNA methylation array with single CpG site resolution . Genomics98 ( 4 ), 288 – 295 ( 2011 ).
  • Biomers.net . www.biomers.net .
  • Wanderer . http://maplab.imppc.org/wanderer/# .
  • Wang X , KangDD , ShenKet al. An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection . Bioinformatics28 ( 19 ), 2534 – 2536 ( 2012 ).
  • Bioconductor . www.bioconductor.org .
  • Smyth GK . Linear models and empirical bayes methods for assessing differential expression in microarray experiments . Stat. Appl. Genet. Mol. Biol.3 , Article 3 ( 2004 ).
  • Benjamini Y , HochbergY . Controlling the false discovery rate – a practical and powerful approach to multiple testing . J. R. Stat. Soc. Series B (Methodological)57 ( 1 ), 289 – 300 ( 1995 ).
  • The Cancer Genome Atlas: TCGA Data Portal . https://tcga-data.nci.nih.gov/tcga/ .
  • Jass JR . Gastrointestinal polyposes: clinical, pathological and molecular features . Gastroenterol. Clin. North Am.36 ( 4 ), 927 – 946 , viii ( 2007 ).
  • Iacopetta B . Are there two sides to colorectal cancer?Int. J. Cancer101 ( 5 ), 403 – 408 ( 2002 ).
  • Beggs AD , JonesA , El-BahrawyM , AbulafiM , HodgsonSV , TomlinsonIP . Whole-genome methylation analysis of benign and malignant colorectal tumours . J. Pathol.229 ( 5 ), 697 – 704 ( 2013 ).
  • Zhang FF , CardarelliR , CarrollJet al. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood . Epigenetics6 ( 5 ), 623 – 629 ( 2011 ).
  • Zhang FF , SantellaRM , WolffM , KappilMA , MarkowitzSB , MorabiaA . White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population . Epigenetics7 ( 6 ), 606 – 614 ( 2012 ).
  • Delgado-Cruzata L , ZhangW , McdonaldJAet al. Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African–American, and Afro-Caribbean breast cancer survivors . J. Nutr.145 ( 4 ), 783 – 790 ( 2015 ).
  • Kardon T , NoelG , VertommenD , SchaftingenEV . Identification of the gene encoding hydroxyacid-oxoacid transhydrogenase, an enzyme that metabolizes 4-hydroxybutyrate . FEBS Lett.580 ( 9 ), 2347 – 2350 ( 2006 ).
  • Kim YH , LeeHC , KimSYet al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations . Ann. Surg. Oncol.18 ( 8 ), 2338 – 2347 ( 2007 ).
  • Oster B , ThorsenK , LamyPet al. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas . Int. J. Cancer129 ( 12 ), 2855 – 2866 ( 2011 ).
  • Kim JY , TillisonKS , ZhouS , LeeJH , SmasCM . Differentiation-dependent expression of Adhfe1 in adipogenesis . Arch. Biochem. Biophys.464 ( 1 ), 100 – 111 ( 2007 ).
  • Lyon RC , JohnstonSM , PanopoulosA , AlzeerS , McGarvieG , EllisEM . Enzymes involved in the metabolism of gamma-hydroxybutyrate in SH-SY5Y cells: identification of an iron-dependent alcohol dehydrogenase ADHFe1 . Chem. Biol. Interact.178 ( 1–3 ), 283 – 287 ( 2009 ).
  • Hibi K , GotoT , KitamuraYHet al. Methylation of the TFPI2 gene is frequently detected in advanced gastric carcinoma . Anticancer Res.30 ( 10 ), 4131 – 4133 ( 2010 ).
  • Wang S , XiaoX , ZhouXet al. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma . BMC Cancer10 , 617 ( 2010 ).
  • Ashktorab H , RahiH , WansleyDet al. Toward a comprehensive and systematic methylome signature in colorectal cancers . Epigenetics8 ( 8 ), 807 – 815 ( 2013 ).
  • Exner R , PulvererW , DiemMet al. Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers . Br. J. Cancer113 ( 7 ), 1035 – 1045 ( 2015 ).
  • Wong CM , NgYL , LeeJMet al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma . Hepatology45 ( 5 ), 1129 – 1138 ( 2007 ).
  • Sparmann A , Van LohuizenM . Polycomb silencers control cell fate, development and cancer . Nat. Rev. Cancer6 ( 11 ), 846 – 856 ( 2006 ).
  • Glockner SC , DhirM , YiJMet al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer . Cancer Res.69 ( 11 ), 4691 – 4699 ( 2009 ).
  • Moon JW , LeeSK , LeeJOet al. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer . J. Exp. Clin. Cancer Res.33 , 4 ( 2014 ).
  • Lin PC , LinJK , LinCHet al. Clinical relevance of plasma DNA methylation in colorectal cancer patients identified by using a genome-wide high-resolution array . Ann. Surg. Oncol.22 ( Suppl. 3 ), 1419 – 1427 ( 2015 ).
  • Heller G , BabinskyVN , ZieglerBet al. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients . Carcinogenesis34 ( 3 ), 513 – 521 ( 2013 ).
  • Li HP , PengCC , ChungICet al. Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma . Oncotarget4 ( 11 ), 2154 – 2165 ( 2013 ).
  • Shu Y , WangB , WangJ , WangJM , ZouSQ . Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma . World J. Gastroenterol.17 ( 29 ), 3407 – 3419 ( 2011 ).
  • Chiang JH , ChengWS , HoodL , TianQ . An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature . OMICS18 ( 5 ), 310 – 323 ( 2014 ).
  • Kamalakaran S , VaradanV , Giercksky RussnesHEet al. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables . Mol. Oncol.5 ( 1 ), 77 – 92 ( 2011 ).
  • Lin YL , WangYL , FuXL , MaJG . Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma . Med. Sci. Monit.20 , 2380 – 2385 ( 2014 ).
  • Lin YlL , MaJH , LuoXL , GuanTY , LiZG . Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer . J. Int. Med. Res.41 ( 1 ), 48 – 54 ( 2014 ).
  • Zhang D , ZhaoW , LiaoX , BiT , LiH , CheX . Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer . Oncol. Rep.28 ( 5 ), 1785 – 1791 ( 2012 ).
  • Tommasi S , KarmDL , WuX , YenY , PfeiferGP . Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer . Breast Cancer Res.11 ( 1 ), R14 ( 2009 ).
  • Wong KY , YimRL , KwongYLet al. Epigenetic inactivation of the MIR129-2 in hematological malignancies . J. Hematol. Oncol.6 , 16 ( 2013 ).
  • Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond . Nat. Rev. Genet.13 ( 7 ), 484 – 492 ( 2012 ).
  • Kulis M , QueirosAC , BeekmanR , Martin-SuberoJI . Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer . Biochim. Biophys. Acta1829 ( 11 ), 1161 – 1174 ( 2013 ).
  • Rideout WM 3rd , CoetzeeGA , OlumiAF , JonesPA . 5-methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes . Science249 ( 4974 ), 1288 – 1290 ( 1990 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.